Formation continue > SSP/SST – EFP Joint Annual Conference 2021 17.06.2021 08:30 - 18.06.2021 16:45 12 Credits Virtual Registration Program Virtual Registration Scientific Programme Thursday, 17 June 2021 Joint Sessions, Virtual Room 1 08:30 – 09:30 Joint SSP-EFP Session COVID-19 08:30 – 08:40 COVID: the most important messages Alexandra Calmy (Geneva, Switzerland) 08:42 – 08:52 COVID in children: (including multisystem inflammatory syndrome) Arnaud L’Huillier (Geneva, Switzerland) 08:52 – 09:02 Acute respiratory failure in COVID patients outside the ICU Dan Adler (Geneva, Switzerland) 09:02 – 09:12 COVID and vascular disease (vasculitis, thromboembolic disorders..) Marc Righini (Geneva, Switzerland) 09:12 – 09:22 Swiss COVID lung study Manuela Funke-Chambour (Bern, Switzerland) Joint Sessions, Virtual Room 2 08:30 – 09:30 Joint SSP-EFP Session Sleep disordered breathing 1 08:30 – 08:48 New Swiss recommendations 2020 for the diagnosis and treatment of sleep apnoea Raphaël Heinzer (Lausanne, Switzerland) 08:48 – 09:06 Residual sleepiness in patients treated for sleep apnoea Jean-Louis Pepin (Grenoble, France) 09:06 – 09:24 New treatments for OSA Malcolm Kohler (Zürich, Switzerland) Joint Sessions, Virtual Room 3 08:30 – 09:30 Joint SSP-EFP Session E-cigarettes 08:30 – 08:48 Effects of e-cigarettes on imaging Sylvia Nyilas (Bern, Switzerland) 08:50 – 09:08 E-cigarettes and „Heat not burn devices“: an individual opportunity, but risks for society Jacques Cornuz (Lausanne, Switzerland) 09:10 – 09:28 Impact of e-cigarettes on smoking in adolescents Jürg Barben (St. Gallen, Switzerland) Page 1 / 11 Scientific Programme Joint Sessions, Virtual Room 1 09:45 – 10:45 Joint SSP-EFP Session ILD 2: Sarcoidosis Chair: Thomas Geiser (Bern, Switzerland) 09:45 – 10:03 Sarcoidosis (in Switzerland): What’s new? Martin Brutsche (St. Gallen, Switzerland) 10:05 – 10:23 Pulmonary sarcoidosis – new treatment options 10:25 – 10:43 Cardiac sarcoidosis – diagnosis and treatment Yurdagul Uzunhan (Paris, France) Joint Sessions, Virtual Room 2 09:45 – 10:45 Joint SSP-EFP Session Sleep disordered breathing 2 09:45 – 10:03 Drug induced sleep endoscopy » (DISE): for whom and why? Nicolas Dulguerov (Geneva, Switzerland) 10:05 – 10:23 Insomnia and OSA Sandrine Launois (Paris, France) 10:25 – 10:43 Specific aspects of obstructive sleep apnea in children Claudine Gysin (Zürich, Switzerland) Joint Sessions, Virtual Room 3 09:45 – 10:45 Joint SSP/EFP Session Pulmonary rehabilitation 09:45 – 10:03 Benefits of rehabilitation in comparison to inhalation therapy Bernard Egger (Rolle, Switzerland) 10:03 – 10:21 Combination of in- and outpatient rehabilitation programs Jean-Marie Grosbois (Lille, France) 10:21 – 10:39 Obstacles for respiratory rehabilitation programmes: how to move forward? Swantje Beyer (Winterthur, Switzerland) Joint Sessions, Virtual Room 1 11:00 – 12:00 Joint ERS-SSP/EFP Session Interstitial lung diseases 1 11:00 – 11:18 Hypersensitivity Pneumonitis – Diagnosis and treatment 11:20 – 11:38 New antifibrotic drugs Katrin Hostettler (Basel, Switzerland) 11:40 – 11:58 Secrets of radiological ILD diagnosis and use of AI Lukas Ebner (Bern, Switzerland) Page 2 / 11 Scientific Programme Joint Sessions, Virtual Room 2 11:00 – 12:00 Joint SSP-EFP Session Sleep disordered breathing 3 11:00 – 11:18 Sleep apnoea and cardiovascular risk factors: where are we? New biomarkers? 11:20 – 11:38 SOMNEF study: Sleep patterns and major sleep complaints: a global perspective Franck Soyez (Antony, France) 11:40 – 11:58 Emerging countries: prevalence and impact of sleep apnoea in sub- Saharan Africa: BeSAS study Prudence Wachinou (Cotonou, Benin) Joint Sessions, Virtual Room 3 11:00 – 12:00 Joint SSP/EFP Session The lung and the environment 11:00 – 11:18 Ambient air pollution and the COVID pandemic – what is the link? Nino Künzli (Basel, Switzerland) 11:20 – 11:38 COPD and domestic pollution Chantal Raherison (Bordeaux, France) 11:40 – 11:58 The lung and climate changes Agnès Hamzaoui (Tunis, Tunisia) Industry Sessions, Virtual Room 1 12:15 – 13:00 Satellite Lunch Symposium OM Pharma Suisse Particle size matters – do not stop halfway Industry Sessions, Virtual Room 2 12:15 – 13:00 Satellite Lunch Symposium Sanofi Severe Asthma Industry Sessions, Virtual Room 3 12:15 – 13:00 Satellite Lunch Symposium Vertex Transforming Care in Cystic Fibrosis: The Past, The Present and The Future Page 3 / 11 Scientific Programme Joint Sessions, Virtual Room 1 13:15 – 14:15 Joint ERS-SSP/EFP Session Secondary interstitial lung diseases 13:15 – 13:33 Pulmonary manifestations of graft vs host disease after stem cell transplantation Anne Bergeron (Paris, France) 13:35 – 13:53 Pulmonary diseases related to immunotherapies Jérôme Plojoux (Geneva, Switzerland) 13:55 – 14:13 Non infectious disorders after lung transplantation Christian Benden (Zurich, Switzerland) Joint Sessions, Virtual Room 2 13:15 – 14:15 Joint SSP-EFP Session Severe Asthma 13:15 – 13:33 Burden of systemic corticosteroid therapy in asthma Louis-Philippe Boulet (Quebec, Canada) 13:35 – 13:53 Presentation of the Swiss Severe Asthma Registry Jörg Leuppi (Liestal, Switzerland) 13:55 – 14:13 Update on biological treatments? Roland Buhl (Mainz, Germany) Industry Sessions, Virtual Room 3 13:15 – 14:15 Satellite Atelier Merck New treatment options in pulmonary arterial hypertension Industry Sessions, Virtual Room 3 14:15 – 15:00 Satellite Symposium Astra Zeneca Epithelial cytokines in the airway – Is there a new master switch? Joint Sessions, Virtual Room 1 14:30 – 15:30 Joint Session SSP-EFP Thrombo-embolic disease 14:30 – 14:48 Acute pulmonary embolism 14:50 – 15:08 Post PE management Laurent Bertoletti (St Etienne, France) Page 4 / 11 Scientific Programme 15:10 – 15:28 Balloon pulmonary angioplasty (BPA) for CTEPH Frédéric Lador (Geneva, Switzerland) Joint Sessions, Virtual Room 2 14:30 – 15:30 Joint Session SSP-EFP Pulmonary function testing 14:30 – 14:48 Impact of the new prediction equations (GLI) on patient classification Part 1: Spirometry Konrad Bloch (Zürich, Switzerland) 14:50 – 15:08 Impact of the new prediction equations (GLI) on patient classification Part 2: Pulmonary volumes and DLCO Bruno Degano (Grenoble, France) 15:10 – 15:28 Challenges of implementing spirometry in emerging countries Andre Amaral (London, United Kingdom) Industry Sessions, Virtual Room 3 15:15 – 16:00 Satellite Symposium / Atelier Joint Sessions, Virtual Room 1 15:45 – 16:45 Joint SSP-EFP Session Pulmonary Arterial Hypertension 15:45 – 16:03 Assessment of cardiac output: where is the truth? Léon Genecand (Geneva, Switzerland) 16:05 – 16:23 Haemodynamic definition of PH and exercise right heart catheterization Silvia Ulrich (Zürich, Switzerland) 16:25 – 16:43 New treatments and treatment strategy in PAH Marc Humbert (Paris, France) Joint Sessions, Virtual Room 2 15:45 – 16:45 Joint Session SSP-EFP Pulmonary function test challenge Chair: Anh-Tuan Dinh-Xuan (Paris, France) Chair: Pierre-Olivier Bridevaux (Sion, Switzerland) 15:45 – 16:12 Adult case presentations Anh-Tuan Dinh-Xuan (Paris, France) Pierre-Olivier Bridevaux (Sion, Switzerland) 16:15 – 16:42 Pediatric case presentations Sylvain Blanchon (Lausanne, Switzerland) Page 5 / 11 Scientific Programme Industry Sessions, Virtual Room 3 16:15 – 17:00 Satellite Symposium / Atelier Industry Sessions, Virtual Room 1 17:15 – 18:00 Satellite Atelier OM Pharma Suisse Oscillometry – how and when to use? Joint Sessions, Virtual Room 2 17:15 – 18:15 Joint SSP-EFP Session Round table on collaboration and research within the EFP Industry Sessions, Virtual Room 3 17:15 – 18:00 Satellite Symposium / Atelier Page 6 / 11 Scientific Programme Friday, 18 June 2021 Joint Sessions, Virtual Room 1 08:45 – 09:45 Joint Session SSP-EFP Functional respiratory disorders 08:45 – 09:03 Dysfunctional breathing, hyperventilation Syndrome (including COVID- related) Stephen Fowler (Manchester, United Kingdom) 09:05 – 09:23 Inducible laryngeal obstruction (ILO) Jörg Edgar Bohlender (Zürich, Switzerland) 09:25 – 09:43 Dysfunctional breathing under NIV Marjolaine Georges (Dijon, France) Joint Sessions, Virtual Room 2 08:45 – 09:45 Joint Session SSP-EFP Lung cancer: special surgical situations 08:45 – 09:03 Surgical management of pulmonary metastases Michel Gonzalez (Lausanne, Switzerland) 09:05 – 09:23 How to manage post-segmentectomy N2 disease ? Gregor Kocher (Bern, Switzerland) 09:25 – 09:43 Expanding surgery for oligometastatic stage IV lung cancer Didier Lardinois (Basel, Switzerland) Joint Sessions, Virtual Room 3 08:45 – 09:45 Joint Session SSP-EFP Mycobacteria 2 08:45 – 09:03 Latent tuberculosis – newly defined? How to diagnose? How to treat? Otto Schoch (St. Gallen, Switzerland) 09:05 – 09:23 Non tuberculous mycobacteria: the new kid on the block? Nicolas Veziris (Paris, France) 09:25 – 09:43 Non tuberculous mycobacteria and HIV Olivier Nawej Tshikung (Switzerland) Joint Sessions, Virtual Room 1 10:00 – 11:00 Joint SSP/EFP Session Non-invasive ventilation Page 7 / 11 Scientific Programme 10:00 – 10:18 Swiss 2020 NIV guidelines Jean-Paul Janssens (Geneva, Switzerland) 10:20 – 10:38 NIV: Trouble shooting Esther Irene Schwarz (Zürich, Switzerland) 10:40 – 10:58 High-Flow versus NIV in chronic respiratory failure Grégoire Gex (Sion, Switzerland) Joint Sessions, Virtual Room 2 10:00 – 11:00 Joint Session SSP-EFP Lung cancer: proximal airway involvment 10:00 – 10:18 Endoscopic management of benign proximal airway stenosis Hervé Dutau (Marseille, France) 10:20 – 10:38 Surgical management of benign proximal airway stenosis Emmanuel Martinod (Paris, France) 10:40 – 10:58 Is the 3D printed stent the stent we all dream of? Daniel Franzen (Zürich, Switzerland) Joint Sessions, Virtual Room 3 10:00 – 11:00 Joint SSP-EFP Session Mycobacteria 1 10:00 – 10:18 Tuberculosis locally and globally in 2021 Gunar Günther (Bern, Switzerland) 10:20 – 10:38 Tuberculosis «goes molecular» – state of the art in the diagnosis of active disease and resistance Peter Keller (Bern, Switzerland) 10:40 – 10:58 «Luminous dots» – current tuberculosis research in the clinical context Joint Sessions, Virtual Room 1 11:15 – 12:15 Joint Session SSP-EFP Respiratory disorders at extremes of life 11:15 – 11:33 Sleep disorders in infants and toddlers Daniel Trachsel (Basel, Switzerland) 11:35 – 11:53 NIV and CPAP in patients over 75: is it possible? Chloé Cantero (Geneva, Switzerland) 11:55 – 12:13 Periodical breathing and heart failure: where are we today? Marie Pia d’Ortho (Paris, France) Page 8 / 11 Scientific Programme Joint Sessions, Virtual Room 2 11:15 – 12:15 Joint SSP-EFP Session Lung Cancer 11:15 – 11:33 Update on evidences for lung cancer screening Christophe von Garnier (Lausanne, Switzerland) 11:35 – 11:53 Lung cancer screening in Switzerland – where are we? Milo Puhan (Zürich, Switzerland) 11:55 – 12:13 Targeted treatment in lung cancer Catherine Labbé (Quebec, Canada) Joint Sessions, Virtual Room 3 11:15 – 12:15 Joint SSP-EFP Session Vaccination in SARS-CoV-2 infection Chair: Claire Andrejak (France) Industry Sessions, Virtual Room 1 12:30 – 13:15 Satellite Symposium Novartis From ICS to biologicals: maintenance therapy in an inhaler? Industry Sessions, Virtual Room 2 12:30 – 13:15 Satellite Symposium Industry Sessions, Virtual Room 3 12:30 – 13:15 Satellite Symposium Paediatric Pulmology Sessions, Virtual Room 1 13:30 – 14:30 Pediatric session Respiratory failure in pediatric patients 13:30 – 13:48 Use of high flow humidified oxygen therapy in children Jürg Hammer (Basel, Switzerland) 13:50 – 14:08 Pre and peri operative preparation to NIV for high risk children before major surgery Regula Corbelli (Geneva, Switzerland) 14:10 – 14:28 Long term NIV in children Miriam Giarrana (Zürich, Switzerland) Page 9 / 11 Scientific Programme Joint Sessions, Virtual Room 2 13:30 – 14:30 Joint SSP-EFP Session Pulmonary Challenge Chair: Konrad Bloch (Zürich, Switzerland) Chair: Thomas Brack (Glarus, Switzerland) Industry Sessions, Virtual Room 3 13:30 – 14:15 Satellite Atelier Paediatric Pulmology Sessions, Virtual Room 1 14:45 – 15:45 Pediatric Grand Rounds Chair: Isabelle Rochat (Lausanne, Switzerland) Chair: Nicolas Regamey (Luzern, Switzerland) Joint Sessions, Virtual Room 2 14:45 – 15:45 Joint Session SSP-EFP Pleural disease 14:45 – 15:03 Pleural fibrinolysis update of literature and practices Benoit Bédat (Geneva, Switzerland) 15:05 – 15:23 New guidelines for the management of mesothelioma Ilhan Inci (Zürich, Switzerland) 15:25 – 15:43 Molecular diagnostic in the management of respiratory infections – any news? Daiana Stolz (Basel, Switzerland) Industry Sessions, Virtual Room 3 14:45 – 15:30 Satellite Atelier Paediatric Pulmology Sessions, Virtual Room 1 16:00 – 17:00 Pediatric Session Pulmonary disease from childhood to adult life 16:00 – 16:18 Early origin of pulmonary disease Sejal Saglani (London, United Kingdom) 16:20 – 16:38 New treatment options in cystic fibrosis Alexander Möller (Zürich, Switzerland) 16:40 – 16:58 Asthma from childhood to adult life Page 10 / 11 Scientific Programme Session, Virtual Room 2 16:00 – 17:00 SSP Best Swiss scientific research 2020/2021 Industry Sessions, Virtual Room 3 16:00 – 16:45 Satellite Atelier Powered by TCPDF (www.tcpdf.org) Page 11 / 11